Clinical efficacy and safety of tolterodine extended release for treatment of overactive bladder. A phase III, 12-week, randomised, double-blind, placebo- and active (oxybutynin)-controlled study in Japan and Korea
Homma Y. 1, Paick J. S. 2, Lee J. G. 3, Kawabe K. 4
1. Tokyo University Hospital, 2. Seoul National University Hospital, 3. Korea University Anam Hospital, 4. Yaizu General Hospital
Abstract Category
Reconstructive Surgery: LUT
|
|
Abstract 221
|
|
|
Non Discussion Poster
Scientific Non Discussion Poster Session 18
|
|
|